• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

48.19 +1.12 (+2.38%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,787,447
Open 48.27
Bid (Size) 48.25 (4)
Ask (Size) 48.47 (1)
Prev. Close 47.07
Today's Range 47.55 - 49.03
52wk Range 46.90 - 139.74
Shares Outstanding N/A
Dividend Yield 4.56%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio?
Today 8:46 EDT
Ten large-cap stocks, including Novo Nordisk and UPS, tumbled last week on weak earnings and guidance cuts. 
Via Benzinga
Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity?
August 02, 2025
Competition from all sides is causing Novo Nordisk to revise its expectations for 2025. 
Via The Motley Fool

Performance

YTD
-44.9%
-44.9%
1 Month
-30.3%
-30.3%
3 Month
-30.3%
-30.3%
6 Month
-41.7%
-41.7%
1 Year
-62.2%
-62.2%

More News

Read More
Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure
August 02, 2025
Via Benzinga
Topics Economy Government
Why Eli Lilly Stock Topped the Market Today
August 01, 2025
Via The Motley Fool
Topics Government
Why Novo Nordisk Stock Bumped Higher on Friday
August 01, 2025
Via The Motley Fool
Topics Government
Will Hims & Hers Fall Along With Novo Nordisk?
August 01, 2025
Via MarketBeat
Why Novo Nordisk Stock Imploded This Week
August 01, 2025
Via The Motley Fool
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
August 01, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under Medicaid, Medicare
August 01, 2025
Via Stocktwits
Topics Government
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
August 01, 2025
Via Benzinga
Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients
August 01, 2025
Via Benzinga
Topics Government
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
August 01, 2025
From Pomerantz LLP
Via GlobeNewswire
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
August 01, 2025
Via Benzinga
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
August 01, 2025
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
July 31, 2025
Via Stocktwits
Topics Government
Why Novo Nordisk Stock Crumbled Again Today
July 31, 2025
Via The Motley Fool
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
July 31, 2025
From Glancy Prongay & Murray LLP
Via Business Wire
Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health
July 31, 2025
Via Benzinga
Why Novo Nordisk Stock Plummeted Today
July 30, 2025
Via The Motley Fool
Topics Stocks
Novo Nordisk A/S (NVO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
July 30, 2025
From Law Offices of Howard G. Smith
Via Business Wire
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
July 30, 2025
Via Stocktwits
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
July 30, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2025
Via Benzinga
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
July 30, 2025
From The Law Offices of Frank R. Cruz
Via Business Wire
Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know
July 30, 2025
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.19
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 08/01/25 07:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap